Long noncoding RNA TINCR facilitates hepatocellular carcinoma progression and dampens chemosensitivity to oxaliplatin by regulating the miR-195-3p/ST6GAL1/NF-κB pathway
Jie Mei(Sun Yat-sen University), Rong Guo(Sun Yat-sen University), Anna Kan(Sun Yat-sen University), Chengyou Yu(Sun Yat-sen University), Wei Wei(Zhujiang Hospital), Yuhao Tang(Jiangsu Police Officer College), Zhiwei Ye(Liaoning University), Wen‐Ping Lin(Sun Yat-sen University), Yuhua Wen(Tongji University), Lianghe Lu(Sun Yat-sen University), Shaohua Li(Sun Yat-sen University), Jingwen Zou(Sun Yat-sen University)
Cited by 30
Related Papers
Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
|JAMA Oncology|2019|559
Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
|Journal of Clinical Oncology|2020|217
Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy <i>versus</i> lenvatinib alone for advanced hepatocellular carcinoma
|Therapeutic Advances in Medical Oncology|2021|216